Characterizing crystal disorder of trospium chloride: A comprehensive,13C CP/MAS NMR, DSC, FTIR, and XRPD study

Journal of Pharmaceutical Sciences

Volumn 102, Issue 4, 2013, Pages 1235-1248

  Urbanova, Martina ^a   Sturcova, Adriana ^a   Brus, Jiri ^a   Benes, Hynek ^a   Skorepova, Eliska ^b   Kratochvil, Bohumil ^b   Cejka, Jan ^b   Sedenkova, Ivana ^a   Kobera, Libor ^a   Policianova, Olivia ^a   Sturc, Antonin ^c  

^a INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^c Interpharma As   (Czech Republic)

Author keywords

Disorder; DSC; Factor analysis; FTIR; Polymorphism; Solid state NMR; Trospium chloride; X ray diffractometry

Indexed keywords

ALCOHOL; CARBON 13; TROSPIUM CHLORIDE; WATER;

ARTICLE; C CROSS POLARIZATION MAGIC ANGLE SPINNING; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; INFRARED SPECTROSCOPY; POLARIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY DIFFRACTION;

EID: 84874711527     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23457     Document Type: Article

References (33)

1. Zakrzewski A, Zakrzewski M. 2006. Solid state characterization of pharmaceuticals. Oxford, UK: Pergamon.
2. Sturcova A, His I, Apperley DC, Sugiyama J, Jarvis MC. 2004. Structural details of crystalline cellulose from higher plants. Biomacromolecules 5:1333-1339.
3. VanderHart DL, Atalla RH. 1984. Studies of microstructure in native celluloses using solid-state carbon-13 NMR. Macromolecules 17(8):1465-1472.
4. Bernstein J. 2002. Polymorphism in molecular crystals. Oxford, UK: Clarendon Press.
5. Clawson JS, Kennedy-Gabb S, Lee AY, Copley RCB. 2011. One-phase crystal disorder in pharmaceutical solids and its implication for solid-state stability. J Pharm Sci 100(10):4302-4316.
6. Copley RCB, Barnett SA, Karamertzanis PG, Harris KDM, Kariuki BM, Xu M, Nickels EA, Lancaster RW, Price SL. 2008. Predictable disorder versus polymorphism in the rationalization of structural diversity: A multidisciplinary study of eniluracil. Cryst Growth Des 8:3474-3481.
7. Gavezzotti A. 2007. A solid-state chemist's view of the crystal polymorphism of organic compounds. J Pharm Sci 96:2232-2241.
8. Borodi G, Pop MM, Onija O, Filip X. 2012. Distinct disordered forms of promethazine hydrochloride: A case of intergrowth of polymorphic domains? Cryst Growth Des 12:5846-5851.
9. Kato F, Otsuka M, Matsuda Y. 2006. Kinetic study of the transformation of mefenamic acid polymorphs in various solvents and under high humidity conditions. Int J Pharm 321(1-2):18-26.
10. Raus V, Sturcova A, Dybal J, Slouf M, Vackova T, Salek P, Kobera L, Vlcek P. 2012. Activation of cellulose by 1, 4-dioxane for dissolution in N, N-dimethylacetamide/LiCl. Cellulose 19:1893-1906.
11. Patel JR, Carlton RA, Yuniatine F, Needham TE, Wu LM, Vogt FG. 2012. Preparation and structural characterization of amorphous spray-dried dispersions of tenoxicam with enhanced dissolution. J Pharm Sci 101(2):641-663.
12. Heinz A, Strachan C, Atassi F, Gordon K, Rades T. 2008. Characterizing an amorphous system exhibiting trace crystallinity: A case study with Saquinavir. Cryst Growth Des 8:119-127.
13. Graeser KA, Strachan CJ, Patterson JE, Gordon KC, Rades T. 2008. Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin. Cryst Growth Des 8:128-135.
14. Brus J, Jegorov A. 2004. Through-bonds and through-space solid-state NMR correlations at natural isotopic abundance: Signal assignment and structural study of simvastatin. J Phys Chem A 108:3955-3964.
15. Eads CD, Furnish CM, Noda I, Juhlin KD, Cooper DA, Morrall SW. 2004. Molecular factor analysis applied to collections of NMR spectra. Anal Chem 76:1982-1990.
16. Brus J, Urbanova M, Sedenkova I, Brusova H. 2011. New perspectives of 19F MAS NMR in the characterization of amorphous forms of atorvastatin in dosage formulations. Int J Pharm 409(1-2):62-74.
17. Urbanova M, Brus J, Sedenkova I, Policianova O, Kobera L. 2013. Characterization of solid polymer dispersions of active pharmaceutical ingredients by 19F MAS NMR and factor analysis. Spectrochim Acta A 100:59-66.
18. Fusgen I, Hauri D. 2000. Trospium chloride: An effective option for medical treatment of bladder overactivity. Int Clin Pharmacol Ther 38(5):223-234.
19. Wu XL, Burns ST, Zilm KW. 1994. Spectral editing in CPMAS NMR. Generating subspectra based on proton multiplicities. J Magn Reson 111:29-36.
20. Brus J. 2000. Heating of samples induced by fast magic-angle spinning. Solid State Nucl Magn Reson 16(3):151-160.
21. Husak M, Jegorov A, Brus J, Van Beek W, Pattison P, Christensen M, Favre-Nicolin V, Maixner J. 2007. Metergoline II: Structure solution from powder diffraction data with preferred orientation and from microcrystal. Struct Chem 19(3):517-525.
22. Matejicek P, Brus J, Jigounov A, Plestil J, Uchman M, Prochazka K, Gradzielski M. 2011. On the structure of polymeric composite of metallacarborane with poly(ethylene oxide). Macromolecules 44 (10):3847-3855.
23. Harris RK. 2004. NMR crystallography: The use of chemical shifts. Solid State Sci 6 (10):1025-1037.
24. Simon SL. 2001. Temperature-modulated differential scanning calorimetry: Theory and application. Thermochim Acta 374:55-71.
25. Behme RJ, Brooke D. 2006. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple phase changes during DSC analysis. J Pharm Sci 80:986-990.
26. Koenig JL. 1999. Spectroscopy of polymers. Amsterdam, The Netherlands: Elsevier.
27. Arunan E, Desiraju GR, Klein RA, Sadlej J, Scheiner S, Alkorta I, Clary DC, Crabtree RH, Dannenberg J, Hobza P, Kjaergaard HG, Legon AC, Mennucci B, Nesbitt DJ. 2011. Defining the hydrogen bond: An account. Pure Appl Chem 83:1618-1636.
28. Arunan E, Desiraju GR, Klein RA, Sadlej J, Scheiner S, Alkorta I, Clary DC, Crabtree RH, Dannenberg J, Hobza P, Kjaergaard HG, Legon AC, Mennucci B, Nesbitt DJ. 2011. Definition of the hydrogen bond. Pure Appl Chem 83:1637-1641.
29. 2O (X = Cl, Br, I) complexes via argon predissociation spectroscopy. J Am Chem Soc 120:12361-12362.
30. Robertson WH, Johnson MA. 2003. Molecular aspects of halide ion hydration: The cluster approach. Annual. Rev Phys Chem 54:173-213.
31. Michael Meot-Ner (Mautner). 2005. The ionic hydrogen bond. Chem Rev 105:213-284.
32. Borisevich NA, Buslov DK. 2010. Infrared spectra of brassinolide and castasterone steroid phytohormones and their 24-epi derivatives. J Appl Spectrosc 77(4):491-495.
33. Husak M, Hajkova M, Cejka J, Dusek M, Kratochvil B. 2009. Crystals forms of trospium chloride. Acta Crystallogr Sect A 65:304.